Use of tumor necrosis factor (TNF) inhibitors in patients with HIV/AIDS

被引:57
作者
Gallitano, Stephanie M. [1 ]
McDermott, Laura [1 ]
Brar, Kanwaljit [2 ]
Lowenstein, Eve [1 ]
机构
[1] SUNY Downstate, Dept Dermatol, 450 Clarkson Ave,Box 46, Brooklyn, NY 11203 USA
[2] Natl Jewish Hlth, Div Pediat Allergy & Immunol, Denver, CO USA
关键词
AIDS; autoimmune disease; hidradenitis suppurativa; HIV; inflammatory bowel disease; opportunistic infections; psoriasis; rheumatoid arthritis; tumor necrosis factor-alpha; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-POSITIVE PATIENT; FACTOR-ALPHA; PSORIATIC-ARTHRITIS; INFECTED PATIENT; FACTOR THERAPY; ETANERCEPT; INFLIXIMAB; ACTIVATION; MARKERS;
D O I
10.1016/j.jaad.2015.11.043
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Patients with HIV and AIDS are living longer because of advancements in antiretroviral therapy. These patients are often susceptible to debilitating inflammatory disorders that are refractory to standard treatment. We discuss the relationship of tumor necrosis factor-alpha and HIV and then review 27 published cases of patients with HIV being treated with tumor necrosis factor-alpha inhibitors. This review is limited because no randomized controlled trials have been performed with this patient population. Regardless, we propose that reliable seropositive patients, who are adherent to medication regimens and frequent monitoring and have failed other treatment modalities, should be considered for treatment with tumor necrosis factor-alpha inhibitors.
引用
收藏
页码:974 / 980
页数:7
相关论文
共 33 条
[1]   Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis [J].
Aboulafia, DM ;
Bundow, D ;
Wilske, K ;
Ochs, UI .
MAYO CLINIC PROCEEDINGS, 2000, 75 (10) :1093-1098
[2]   Severe Refractory Hidradenitis Suppurativa in an HIV-Positive Patient Successfully Treated With Infliximab [J].
Alecsandru, Diana ;
Padilla, Belen ;
Aviles Izquierdo, Jose Antonio ;
Fernandez-Cruz, Eduardo ;
Sanchez-Ramon, Silvia .
ARCHIVES OF DERMATOLOGY, 2010, 146 (12) :1343-1345
[3]   Successful use of antitumor necrosis factor-alpha biological therapy in managing human immunodeficiency virus-associated arthritis: Three case studies from Saudi Arabia [J].
Almoallim, Hani ;
Jali, Ibtisam ;
Wali, Ghassan .
JOINT BONE SPINE, 2013, 80 (04) :426-428
[4]   Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab [J].
Bartke, U ;
Venten, I ;
Kreuter, A ;
Gabbay, S ;
Altmeyer, P ;
Brockmeyer, NH .
BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (04) :784-786
[5]   Safe and effective application of anti-TNF-α in a patient infected with HIV and concomitant Crohn's disease [J].
Beltran, B. ;
Nos, P. ;
Bastida, G. ;
Iborra, M. ;
Hoyos, M. ;
Ponce, J. .
GUT, 2006, 55 (11) :1670-1671
[6]   Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection [J].
Calabrese, LH ;
Zein, N ;
Vassilopoulos, D .
ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 :18-24
[7]   Pulmonary and nodal tuberculosis in a patient with inflammatory bowel disease and HIV infection treated with infliximab [J].
Carrion, Silvia ;
Domenech, Eugeni ;
Romeu, Joan ;
Domenech, Eugeni .
JOURNAL OF CROHNS & COLITIS, 2009, 3 (03) :220-221
[8]   New insights into HIV-1-primary skin disorders [J].
Cedeno-Laurent, Filiberto ;
Gomez-Flores, Minerva ;
Mendez, Nora ;
Ancer-Rodriguez, Jesus ;
Bryant, Joseph L. ;
Gaspari, Anthony A. ;
Trujillo, Jose R. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2011, 14
[9]   The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease [J].
Cepeda, E. J. ;
Williams, F. M. ;
Ishimori, M. L. ;
Weisman, M. H. ;
Reveille, J. D. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) :710-712
[10]   Septic Shock after Seasonal Influenza Vaccination in an HIV-Infected Patient during Treatment with Etanercept for Rheumatoid Arthritis: a Case Report [J].
De Nardo, Pasquale ;
Bellagamba, Rita ;
Corpolongo, Angela ;
Gentilotti, Elisa ;
Taglietti, Fabrizio ;
Rosati, Silvia ;
Galeazzi, Mauro ;
Sebastiani, Gian Domenico ;
Quinti, Isabella ;
Nicastri, Emanuele .
CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (05) :761-764